Efficacy and Safety of Biosimilar Cetuximab (CETUXA) in Locoregionally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck: A Retrospective Multicenter Analysis. JOC. 2025;24(10s):382-389. doi:10.64149/J.Carcinog.24.10s.382-389